What is the Ipca Laboratories Ltd share price today?

The share price of NSE:IPCALAB-EQ on 01 Oct 2026 (as of 15:03:53 IST) is ₹1944.

What is the NSE:IPCALAB-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:IPCALAB-EQ 52 week high low range shows a high of ₹2038 and a low of ₹1251.6.

What is the Ipca Laboratories Ltd market cap?

As on 01 Oct 2026, Ipca Laboratories Ltd market cap is ₹488964000000.

What is the shareholding pattern of Ipca Laboratories Ltd Stock?

The shareholding pattern of Ipca Laboratories Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 44.72% Foreign Institutional Investors (FII): 10.72% Domestic Institutional Investors (DII): 5.89% Mutual Funds: 31.15% Retail & Others: 7.52% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Ipca Laboratories Ltd?

The Price-to-Earnings (PE) ratio of Ipca Laboratories Ltd is 37.3312, and the Price-to-Book (PB) ratio is 5.0453, as on 01 Oct 2026.

Ipca Laboratories Share Price

1950.10+0.00 (+0.01%)

+48.90% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Login to analyze with FIA

1 Day

+0.01%

1 Week

+1.16%

1 Month

-0.06%

3 Month

+12.45%

6 Month

+25.60%

YTD

+37.44%

1 Year

+48.90%

5 Year

+83.54%

10 Year

+568.70%

Max

+37044.76%

1D

1W

1M

3M

6M

YTD

1Y

5Y

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

1935.10

1933.60

1797.00

1674.40

1470.00

1270.00

High

1984.50

1994.00

2038.00

About

IPCA Laboratories Limited incorporated in the year 1949, is integrated pharmaceutical company manufacturing and marketing various formulations and many API’s covering various therapeutic segments. The products of the company are Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

IPCALABNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9-7.8 (-0.44%)

1722

1855

4,24,202Cr

10064+284 (2.90%)

9621.50

10064

2,64,141Cr

4650+36.6 (0.79%)

4532

4675

1,74,402Cr

2323-82.5 (-3.43%)

2206.10

2441.90

1,26,811Cr

1240.6-4.9 (-0.39%)

1182

1254.20

1,23,685Cr

1368.3+16.3 (1.21%)

1336.70

1368.30

1,11,868Cr

1396.9+18 (1.31%)

1357

1396.90

1,11,650Cr

2475-17.8 (-0.71%)

2457.90

2528

1,02,196Cr

1694.5+13.1 (0.78%)

1647.20

1697.40

96,951Cr

2015.9+4.9 (0.24%)

1974

2033.80

91,301Cr

1950.1+22.3 (1.16%)

1921.40

1984.50

49,472Cr

Ipca Laboratories Share Price

1950.10+0.00 (+0.01%)

+48.90% past 1 Year

Financial overview

Compounded Sales Growth

10 years13%

5 years12%

3 years16%

Last year8%

Compounded Profit Growth

10 years28%

5 years0%

3 years34%

Last year51%

Stock Price CAGR

10 years21%

5 years13%

3 years26%

1 year49%

Return on Equity

10 years14%

5 years13%

3 years12%

Last year16%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
13%	12%	16%	8%
28%	0%	34%	51%
21%	13%	26%	49%
14%	13%	12%	16%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

IPCALAB

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
1,950.1	₹49472 Cr	37.77	15.84	68.53	₹1141 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

%

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020	Sep 2020	Jun 2020	Mar 2020	Dec 2019	Sep 2019	Jun 2019	Mar 2019	Dec 2018	Sep 2018	Jun 2018
₹2788 Cr	₹2388 Cr	₹2393 Cr	₹2557 Cr	₹2309 Cr	₹2247 Cr	₹2245 Cr	₹2355 Cr	₹2093 Cr	₹2033 Cr	₹2053 Cr	₹2034 Cr	₹1585 Cr	₹1512 Cr	₹1546 Cr	₹1601 Cr	₹1586 Cr	₹1289 Cr	₹1430 Cr	₹1544 Cr	₹1566 Cr	₹1115 Cr	₹1410 Cr	₹1361 Cr	₹1534 Cr	₹1074 Cr	₹1213 Cr	₹1284 Cr	₹1078 Cr	₹880 Cr	₹1006 Cr	₹1012 Cr	₹875 Cr
₹25 Cr	₹94 Cr	₹20 Cr	₹28 Cr	₹33 Cr	₹26 Cr	₹20 Cr	₹26 Cr	₹21 Cr	₹19 Cr	₹22 Cr	₹39 Cr	₹45 Cr	₹36 Cr	₹31 Cr	₹36 Cr	₹22 Cr	₹15 Cr	₹13 Cr	₹18 Cr	₹21 Cr	₹20 Cr	₹15 Cr	₹15 Cr	₹12 Cr	₹14 Cr	₹18 Cr	₹15 Cr	₹20 Cr	₹15 Cr	₹13 Cr	₹15 Cr	₹14 Cr
₹2813 Cr	₹2482 Cr	₹2413 Cr	₹2584 Cr	₹2342 Cr	₹2273 Cr	₹2265 Cr	₹2381 Cr	₹2113 Cr	₹2052 Cr	₹2075 Cr	₹2073 Cr	₹1630 Cr	₹1548 Cr	₹1577 Cr	₹1637 Cr	₹1608 Cr	₹1304 Cr	₹1443 Cr	₹1563 Cr	₹1587 Cr	₹1135 Cr	₹1425 Cr	₹1377 Cr	₹1546 Cr	₹1087 Cr	₹1231 Cr	₹1299 Cr	₹1099 Cr	₹895 Cr	₹1019 Cr	₹1027 Cr	₹890 Cr
₹2229 Cr	₹2012 Cr	₹1967 Cr	₹2115 Cr	₹1992 Cr	₹1918 Cr	₹1881 Cr	₹2014 Cr	₹1799 Cr	₹1809 Cr	₹1821 Cr	₹1764 Cr	₹1347 Cr	₹1400 Cr	₹1397 Cr	₹1404 Cr	₹1378 Cr	₹1131 Cr	₹1181 Cr	₹1236 Cr	₹1205 Cr	₹938 Cr	₹1096 Cr	₹1053 Cr	₹997 Cr	₹969 Cr	₹990 Cr	₹1068 Cr	₹926 Cr	₹760 Cr	₹817 Cr	₹883 Cr	₹803 Cr
₹695 Cr	₹578 Cr	₹554 Cr	₹573 Cr	₹449 Cr	₹455 Cr	₹483 Cr	₹468 Cr	₹413 Cr	₹341 Cr	₹353 Cr	₹399 Cr	₹353 Cr	₹217 Cr	₹247 Cr	₹297 Cr	₹291 Cr	₹234 Cr	₹321 Cr	₹384 Cr	₹438 Cr	₹249 Cr	₹382 Cr	₹376 Cr	₹600 Cr	₹182 Cr	₹292 Cr	₹281 Cr	₹219 Cr	₹180 Cr	₹248 Cr	₹189 Cr	₹133 Cr
₹12 Cr	₹20 Cr	₹18 Cr	₹20 Cr	₹19 Cr	₹22 Cr	₹17 Cr	₹23 Cr	₹24 Cr	₹29 Cr	₹33 Cr	₹44 Cr	₹31 Cr	₹18 Cr	₹11 Cr	₹9 Cr	₹7 Cr	₹3 Cr	₹1 Cr	₹1 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹3 Cr	₹4 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹6 Cr	₹5 Cr	₹2 Cr	₹5 Cr
₹572 Cr	₹404 Cr	₹446 Cr	₹392 Cr	₹331 Cr	₹128 Cr	₹368 Cr	₹345 Cr	₹290 Cr	₹77 Cr	₹289 Cr	₹225 Cr	₹252 Cr	₹129 Cr	₹169 Cr	₹224 Cr	₹223 Cr	₹170 Cr	₹261 Cr	₹326 Cr	₹380 Cr	₹195 Cr	₹327 Cr	₹321 Cr	₹547 Cr	₹115 Cr	₹237 Cr	₹227 Cr	₹168 Cr	₹129 Cr	₹197 Cr	₹141 Cr	₹81 Cr
₹423 Cr	₹309 Cr	₹364 Cr	₹284 Cr	₹234 Cr	₹66 Cr	₹277 Cr	₹245 Cr	₹199 Cr	₹3 Cr	₹223 Cr	₹137 Cr	₹166 Cr	₹81 Cr	₹116 Cr	₹147 Cr	₹148 Cr	₹141 Cr	₹203 Cr	₹258 Cr	₹309 Cr	₹164 Cr	₹270 Cr	₹269 Cr	₹447 Cr	₹85 Cr	₹200 Cr	₹195 Cr	₹131 Cr	₹97 Cr	₹160 Cr	₹119 Cr	₹68 Cr

Balance Sheet

Consolidated

Standalone

₹

%

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Less Impairment of Assets

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr	₹25 Cr
₹3 Cr	₹3 Cr	₹2 Cr	₹0	₹0	₹0	₹12 Cr	₹0	₹32 L	₹0	₹0	₹0	₹0	₹0	₹14 L	₹48 L	₹2 Cr	₹3 Cr	₹3 Cr
₹8035 Cr	₹6920 Cr	₹6305 Cr	₹5817 Cr	₹5439 Cr	₹4676 Cr	₹3590 Cr	₹3097 Cr	₹2663 Cr	₹2430 Cr	₹2234 Cr	₹2183 Cr	₹1934 Cr	₹1529 Cr	₹1229 Cr	₹1026 Cr	₹838 Cr	₹604 Cr	₹561 Cr
₹8035 Cr	₹6920 Cr	₹6305 Cr	₹5817 Cr	₹5439 Cr	₹4676 Cr	₹3590 Cr	₹3097 Cr	₹2663 Cr	₹2430 Cr	₹2234 Cr	₹2183 Cr	₹1934 Cr	₹1529 Cr	₹1229 Cr	₹1026 Cr	₹838 Cr	₹604 Cr	₹561 Cr
₹8064 Cr	₹6948 Cr	₹6332 Cr	₹5842 Cr	₹5465 Cr	₹4702 Cr	₹3627 Cr	₹3122 Cr	₹2689 Cr	₹2455 Cr	₹2259 Cr	₹2208 Cr	₹1960 Cr	₹1554 Cr	₹1254 Cr	₹1052 Cr	₹865 Cr	₹631 Cr	₹589 Cr
₹1460 Cr	₹1440 Cr	₹1395 Cr	₹73 Cr	₹77 Cr	₹15 Cr	₹14 Cr	₹16 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	-₹66 L	-₹58 L	-₹38 L	₹0
₹109 Cr	₹543 Cr	₹580 Cr	₹652 Cr	₹395 Cr	₹9 Cr	₹89 Cr	₹134 Cr	₹234 Cr	₹347 Cr	₹434 Cr	₹448 Cr	₹292 Cr	₹366 Cr	₹330 Cr	₹195 Cr	₹364 Cr	₹340 Cr	₹300 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹14 Cr	₹7 Cr	₹0	₹5 Cr	₹51 Cr	₹56 Cr	₹2 Cr	₹0	₹0	₹0	₹90 Cr	₹119 Cr	₹53 Cr
₹224 Cr	₹278 Cr	₹306 Cr	₹186 Cr	₹162 Cr	₹132 Cr	₹140 Cr	₹146 Cr	₹158 Cr	₹170 Cr	₹156 Cr	₹174 Cr	₹147 Cr	₹130 Cr	₹93 Cr	₹81 Cr	₹79 Cr	₹65 Cr	₹57 Cr
₹87 Cr	₹52 Cr	₹41 Cr	₹17 Cr	₹14 Cr	₹10 Cr	₹15 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹2 Cr	₹4 Cr	₹3 Cr	₹71 L	₹1 Cr	₹2 Cr	₹0	₹0	₹0
₹98 Cr	₹96 Cr	₹87 Cr	₹47 Cr	₹43 Cr	₹39 Cr	₹32 Cr	₹25 Cr	₹26 Cr	₹25 Cr	₹20 Cr	₹18 Cr	₹15 Cr	₹12 Cr	₹9 Cr	₹5 Cr	₹0	₹0	₹0
₹519 Cr	₹969 Cr	₹1014 Cr	₹902 Cr	₹614 Cr	₹190 Cr	₹290 Cr	₹313 Cr	₹419 Cr	₹548 Cr	₹663 Cr	₹700 Cr	₹459 Cr	₹510 Cr	₹433 Cr	₹282 Cr	₹534 Cr	₹524 Cr	₹410 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹940 Cr	₹846 Cr	₹776 Cr	₹525 Cr	₹558 Cr	₹665 Cr	₹610 Cr	₹524 Cr	₹423 Cr	₹397 Cr	₹421 Cr	₹307 Cr	₹341 Cr	₹268 Cr	₹235 Cr	₹179 Cr	₹120 Cr	₹94 Cr	₹94 Cr
₹732 Cr	₹725 Cr	₹733 Cr	₹488 Cr	₹421 Cr	₹204 Cr	₹305 Cr	₹275 Cr	₹267 Cr	₹316 Cr	₹298 Cr	₹236 Cr	₹251 Cr	₹166 Cr	₹175 Cr	₹100 Cr	₹65 Cr	₹102 Cr	₹43 Cr
₹417 Cr	₹495 Cr	₹559 Cr	₹662 Cr	₹368 Cr	₹177 Cr	₹311 Cr	₹210 Cr	₹239 Cr	₹177 Cr	₹185 Cr	₹325 Cr	₹144 Cr	₹157 Cr	₹201 Cr	₹263 Cr	₹0	₹0	₹0
₹217 Cr	₹317 Cr	₹288 Cr	₹131 Cr	₹120 Cr	₹115 Cr	₹101 Cr	₹89 Cr	₹78 Cr	₹66 Cr	₹66 Cr	₹36 Cr	₹56 Cr	₹42 Cr	₹29 Cr	₹37 Cr	₹31 Cr	₹111 Cr	₹122 Cr
₹2307 Cr	₹2384 Cr	₹2356 Cr	₹1806 Cr	₹1466 Cr	₹1161 Cr	₹1326 Cr	₹1098 Cr	₹1008 Cr	₹956 Cr	₹970 Cr	₹904 Cr	₹791 Cr	₹634 Cr	₹640 Cr	₹579 Cr	₹215 Cr	₹308 Cr	₹259 Cr
₹12350 Cr	₹11744 Cr	₹11097 Cr	₹8623 Cr	₹7622 Cr	₹6066 Cr	₹5258 Cr	₹4549 Cr	₹4116 Cr	₹3960 Cr	₹3892 Cr	₹3812 Cr	₹3211 Cr	₹2697 Cr	₹2327 Cr	₹1912 Cr	₹1614 Cr	₹1463 Cr	₹1259 Cr
₹249 Cr	₹235 Cr	₹119 Cr	₹93 Cr	₹70 Cr	₹56 Cr	₹42 Cr	₹40 Cr	₹43 Cr	₹45 Cr	₹44 Cr	₹255 Cr	₹363 Cr	₹317 Cr	₹149 Cr	₹200 Cr	₹184 Cr	₹137 Cr	₹45 Cr
₹704 Cr	₹1302 Cr	₹1388 Cr	₹1458 Cr	₹791 Cr	₹252 Cr	₹482 Cr	₹465 Cr	₹628 Cr	₹716 Cr	₹867 Cr	₹935 Cr	₹603 Cr	₹617 Cr	₹601 Cr	₹530 Cr	₹455 Cr	₹459 Cr	₹353 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹7722 Cr	₹6995 Cr	₹7021 Cr	₹4353 Cr	₹3749 Cr	₹3201 Cr	₹2986 Cr	₹2633 Cr	₹2464 Cr	₹2318 Cr	₹2177 Cr	₹2546 Cr	₹1932 Cr	₹1579 Cr	₹1339 Cr	₹988 Cr	₹881 Cr	₹779 Cr	₹579 Cr
₹3095 Cr	₹2728 Cr	₹2467 Cr	₹1602 Cr	₹1331 Cr	₹1113 Cr	₹927 Cr	₹692 Cr	₹511 Cr	₹335 Cr	₹163 Cr	₹746 Cr	₹578 Cr	₹475 Cr	₹394 Cr	₹289 Cr	₹243 Cr	₹202 Cr	₹163 Cr
₹0	₹0	₹0	₹0	₹16 Cr	₹16 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹2 L	₹2 Cr
₹4627 Cr	₹4267 Cr	₹4554 Cr	₹2751 Cr	₹2402 Cr	₹2072 Cr	₹2059 Cr	₹1940 Cr	₹1953 Cr	₹1983 Cr	₹2014 Cr	₹1800 Cr	₹1354 Cr	₹1104 Cr	₹944 Cr	₹699 Cr	₹638 Cr	₹577 Cr	₹414 Cr
₹762 Cr	₹616 Cr	₹324 Cr	₹122 Cr	₹294 Cr	₹184 Cr	₹71 Cr	₹36 Cr	₹42 Cr	₹62 Cr	₹94 Cr	₹236 Cr	₹149 Cr	₹121 Cr	₹88 Cr	₹88 Cr	₹38 Cr	₹14 Cr	₹128 Cr
₹210 Cr	₹216 Cr	₹304 Cr	₹303 Cr	₹270 Cr	₹111 Cr	₹71 Cr	₹30 Cr	₹18 Cr	₹22 Cr	₹26 Cr	₹16 Cr	₹9 Cr	₹9 Cr	₹34 Cr	₹41 Cr	₹32 Cr	₹41 Cr	₹9 Cr
₹210 Cr	₹216 Cr	₹304 Cr	₹303 Cr	₹270 Cr	₹111 Cr	₹71 Cr	₹30 Cr	₹18 Cr	₹22 Cr	₹26 Cr	₹16 Cr	₹9 Cr	₹9 Cr	₹34 Cr	₹41 Cr	₹32 Cr	₹41 Cr	₹9 Cr
₹336 Cr	₹317 Cr	₹316 Cr	₹230 Cr	₹170 Cr	₹186 Cr	₹128 Cr	₹128 Cr	₹119 Cr	₹106 Cr	₹85 Cr	₹111 Cr	₹78 Cr	₹53 Cr	₹42 Cr	₹39 Cr	₹0	₹0	₹0
₹26 Cr	₹53 Cr	₹43 Cr	₹10 Cr	₹16 Cr	₹25 Cr	₹11 Cr	₹6 Cr	₹7 Cr	₹11 Cr	₹16 Cr	₹4 Cr	₹4 Cr	₹5 Cr	₹3 Cr	₹1 Cr	₹0	₹0	₹0
₹5973 Cr	₹5475 Cr	₹5558 Cr	₹3434 Cr	₹3164 Cr	₹2629 Cr	₹2402 Cr	₹2171 Cr	₹2170 Cr	₹2218 Cr	₹2270 Cr	₹2198 Cr	₹1609 Cr	₹1300 Cr	₹1117 Cr	₹875 Cr	₹709 Cr	₹632 Cr	₹551 Cr
—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
₹633 Cr	₹763 Cr	₹558 Cr	₹323 Cr	₹719 Cr	₹394 Cr	₹238 Cr	₹90 Cr	₹69 Cr	₹114 Cr	₹0	₹0	₹15 L	₹15 L	₹15 L	₹15 L	₹15 L	₹10 L	₹15 L
₹2731 Cr	₹2560 Cr	₹2471 Cr	₹1743 Cr	₹1858 Cr	₹1595 Cr	₹1323 Cr	₹1073 Cr	₹881 Cr	₹882 Cr	₹837 Cr	₹927 Cr	₹848 Cr	₹741 Cr	₹670 Cr	₹466 Cr	₹380 Cr	₹306 Cr	₹268 Cr
₹2014 Cr	₹1884 Cr	₹1687 Cr	₹989 Cr	₹911 Cr	₹812 Cr	₹895 Cr	₹682 Cr	₹602 Cr	₹500 Cr	₹446 Cr	₹353 Cr	₹450 Cr	₹418 Cr	₹345 Cr	₹367 Cr	₹388 Cr	₹339 Cr	₹268 Cr
₹565 Cr	₹344 Cr	₹297 Cr	₹1853 Cr	₹641 Cr	₹365 Cr	₹181 Cr	₹282 Cr	₹151 Cr	₹36 Cr	₹176 Cr	₹125 Cr	₹76 Cr	₹58 Cr	₹12 Cr	₹10 Cr	₹11 Cr	₹11 Cr	₹9 Cr
₹161 Cr	₹120 Cr	₹325 Cr	₹125 Cr	₹116 Cr	₹78 Cr	₹56 Cr	₹80 Cr	₹68 Cr	₹71 Cr	₹67 Cr	₹80 Cr	₹81 Cr	₹77 Cr	₹91 Cr	₹73 Cr	₹36 Cr	₹0	₹0
₹270 Cr	₹295 Cr	₹197 Cr	₹156 Cr	₹202 Cr	₹193 Cr	₹162 Cr	₹171 Cr	₹174 Cr	₹139 Cr	₹96 Cr	₹129 Cr	₹147 Cr	₹103 Cr	₹92 Cr	₹120 Cr	₹90 Cr	₹175 Cr	₹163 Cr
₹6374 Cr	₹5967 Cr	₹5536 Cr	₹5189 Cr	₹4447 Cr	₹3437 Cr	₹2856 Cr	₹2378 Cr	₹1945 Cr	₹1742 Cr	₹1622 Cr	₹1614 Cr	₹1601 Cr	₹1397 Cr	₹1210 Cr	₹1037 Cr	₹905 Cr	₹831 Cr	₹707 Cr
₹4067 Cr	₹3583 Cr	₹3180 Cr	₹3383 Cr	₹2981 Cr	₹2276 Cr	₹1529 Cr	₹1280 Cr	₹938 Cr	₹786 Cr	₹652 Cr	₹710 Cr	₹810 Cr	₹764 Cr	₹570 Cr	₹458 Cr	₹690 Cr	₹523 Cr	₹448 Cr
₹12350 Cr	₹11744 Cr	₹11097 Cr	₹8623 Cr	₹7622 Cr	₹6066 Cr	₹5258 Cr	₹4549 Cr	₹4116 Cr	₹3960 Cr	₹3892 Cr	₹3812 Cr	₹3211 Cr	₹2697 Cr	₹2327 Cr	₹1912 Cr	₹1614 Cr	₹1463 Cr	₹1259 Cr
₹318	₹274	₹250	₹230	₹215	₹371	₹286	₹247	₹213	₹195	₹179	₹175	₹155	₹123	₹100	₹84	₹69	₹252	₹234
₹318	₹274	₹250	₹230	₹215	₹185	₹143	₹124	₹107	₹97	₹90	₹87	₹78	₹62	₹50	₹42	₹34	₹25	₹23

Cash Flow

Consolidated

Standalone

₹

%

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012	Mar 2011	Mar 2010	Mar 2009	Mar 2008
₹1573 Cr	₹1131 Cr	₹843 Cr	₹745 Cr	₹1136 Cr	₹1389 Cr	₹739 Cr	₹546 Cr	₹291 Cr	₹262 Cr	₹117 Cr	₹361 Cr	₹631 Cr	₹454 Cr	₹364 Cr	₹341 Cr	₹266 Cr	₹118 Cr	₹175 Cr
₹277 Cr	₹728 Cr	₹490 Cr	₹235 Cr	₹195 Cr	₹183 Cr	₹247 Cr	₹187 Cr	₹193 Cr	₹175 Cr	₹211 Cr	₹189 Cr	₹140 Cr	₹126 Cr	₹157 Cr	₹39 Cr	₹70 Cr	₹147 Cr	₹9 Cr
-₹294 Cr	-₹176 Cr	-₹92 Cr	₹49 Cr	-₹273 Cr	-₹236 Cr	-₹264 Cr	-₹122 Cr	-₹84 Cr	-₹104 Cr	₹410 Cr	-₹6 Cr	-₹118 Cr	-₹100 Cr	-₹87 Cr	-₹101 Cr	-₹98 Cr	-₹90 Cr	-₹48 Cr
₹1556 Cr	₹1683 Cr	₹1241 Cr	₹1029 Cr	₹1058 Cr	₹1336 Cr	₹723 Cr	₹612 Cr	₹399 Cr	₹333 Cr	₹738 Cr	₹543 Cr	₹653 Cr	₹480 Cr	₹434 Cr	₹279 Cr	₹238 Cr	₹176 Cr	₹136 Cr
₹1142 Cr	₹1321 Cr	₹945 Cr	₹806 Cr	₹856 Cr	₹1090 Cr	₹570 Cr	₹501 Cr	₹341 Cr	₹282 Cr	₹709 Cr	₹468 Cr	₹522 Cr	₹389 Cr	₹354 Cr	₹214 Cr	₹191 Cr	₹152 Cr	₹106 Cr
-₹247 Cr	-₹870 Cr	-₹1292 Cr	-₹725 Cr	-₹855 Cr	-₹521 Cr	-₹510 Cr	-₹165 Cr	-₹135 Cr	-₹149 Cr	-₹218 Cr	-₹689 Cr	-₹369 Cr	-₹260 Cr	-₹286 Cr	-₹198 Cr	-₹117 Cr	-₹109 Cr	-₹144 Cr
-₹754 Cr	-₹283 Cr	-₹553 Cr	₹507 Cr	₹427 Cr	-₹306 Cr	-₹137 Cr	-₹183 Cr	-₹130 Cr	-₹159 Cr	-₹462 Cr	₹251 Cr	-₹136 Cr	-₹83 Cr	-₹72 Cr	-₹18 Cr	-₹74 Cr	-₹42 Cr	₹37 Cr
₹142 Cr	₹169 Cr	-₹900 Cr	₹588 Cr	₹428 Cr	₹264 Cr	-₹76 Cr	₹153 Cr	₹75 Cr	-₹26 Cr	₹29 Cr	₹29 Cr	₹17 Cr	₹46 Cr	-₹4 Cr	-₹2 Cr	₹5 L	₹1 Cr	-₹71 L
₹925 Cr	₹756 Cr	₹1579 Cr	₹991 Cr	₹559 Cr	₹295 Cr	₹371 Cr	₹218 Cr	₹143 Cr	₹169 Cr	₹140 Cr	₹74 Cr	₹57 Cr	₹11 Cr	₹9 Cr	₹11 Cr	₹11 Cr	₹9 Cr	₹10 Cr
₹0	₹0	₹77 Cr	₹0	₹4 Cr	₹0	₹31 L	₹0	₹0	₹0	₹0	₹0	₹41 L	₹0	₹2 Cr	₹0	₹0	₹0	₹0
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹3 Cr	₹0	₹0	₹0	₹0
₹1066 Cr	₹925 Cr	₹756 Cr	₹1579 Cr	₹991 Cr	₹559 Cr	₹295 Cr	₹371 Cr	₹218 Cr	₹143 Cr	₹169 Cr	₹104 Cr	₹74 Cr	₹57 Cr	₹11 Cr	₹9 Cr	₹11 Cr	₹11 Cr	₹9 Cr

Fundamental Ratios

Consolidated

Standalone

No results found

Ipca Laboratories Share Price

1950.10+0.00 (+0.01%)

+48.90% past 1 Year

02 Jan 25+9D

Bid/Ask

Price

Greeks

Stradle

Custom

CALLS

Qty/ots

PUTS

Sign in to View

Open a free Demat account in minutes to start investing and screening .

Login Sign Up

Ipca Laboratories Share Price

1950.10+0.00 (+0.01%)

+48.90% past 1 Year

Technical meters

Oscillators

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 2

Bearish signals: 3 out of 9 oscillators

RSI

53.55Neutral

STOCH %K

77.72Neutral

MACD Level(12,26)

3.83Buy

Ultimate Oscillator

38.54Sell

Aroon Oscillator

-40.00Sell

BOP

-0.38Sell

CCI

83.99Neutral

Williams %R

-22.28Neutral

Momentum

30.90Buy

Moving averages

Strong SellSellNeutralBuyStrong Buy

Bullish signals: 9

Bearish signals: 0 out of 9 moving averages

EMA 9

1935.53Buy

SMA 9

1940.08Buy

EMA 21

1929.95Buy

SMA 21

1921.89Buy

EMA 50

1910.01Buy

SMA 50

1943.47Buy

EMA 200

1725.70Buy

SMA 200

1679.32Buy

WMA 20

1924.85Buy

Pivot

Classic

Resistance 5

2092.43

Resistance 4

2057.03

Resistance 3

2021.63

Resistance 2

1986.23

Resistance 1

1968.07

Pivot

1950.83

Support 1

1932.67

Support 2

1915.43

Support 3

1880.03

Support 4

1844.63

Support 5

1809.23

High & lows

1 Day

1 Week

1 Month

3 Months

6 Months

Year to Date

1 Year

3 Years

5 Years

10 Years

All Time

Low

1935.10

1933.60

1797.00

1674.40

1470.00

1391.10

1270.00

971.00

669.80

200.00

2.75

High

1984.50

1994.00

2038.00

Returns

+0.00

+22.30

-1.20

+215.90

+397.50

+531.20

+640.40

+980.30

+887.63

+1658.47

+1944.85

Beta

—

Std. deviation %

—

Sign in to view

Open a free Demat account in minutes to start investing and screening .

Ipca Laboratories Share Price

1950.10+0.00 (+0.01%)

+48.90% past 1 Year

Shareholding summary

Promoters

44.72%

FII

11.52%

DII

5.21%

MF

31.07%

Others

7.48%

Promoters

FII

DII

MF

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
44.72%	44.72%	44.72%	44.72%	44.72%	44.72%
11.52%	10.72%	10.63%	10.63%	10.42%	10.67%
5.21%	5.89%	5.89%	6.48%	6.41%	6.27%
31.07%	31.15%	31.24%	30.52%	30.04%	29.61%
7.48%	7.52%	7.52%	7.65%	8.41%	8.73%

Bulk & block deals

Name

Usha Madhukar Chandurkar

Ishares Core Msci Emerging Markets Etf

Ishares Core Emerging Markets Mauritius Co

Ishares Core Msci Emerging Markets Etf

Ishares Core Emerging Markets Mauritius Co

Ishares India Sc Mauritius Company

Ishares Msci India Small-Cap Etf

Ishares Core Msci Emerging Markets Etf

Ishares Core Emerging Markets Mauritius Co

Ishares Core Msci Emerging Markets Etf

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
18 Dec 2024	Sell	600.61 Cr	₹1,501.52	40 L	Bulk	1.576639	BSE
14 Nov 2022	Purchase	13.78 Cr	₹867.55	1.59 L	Block	0.062609	NSE
14 Nov 2022	Sell	13.78 Cr	₹867.55	1.59 L	Block	0.062609	NSE
03 Nov 2022	Purchase	14.73 Cr	₹927.15	1.59 L	Block	0.062609	NSE
03 Nov 2022	Sell	14.73 Cr	₹927.15	1.59 L	Block	0.062609	NSE
25 Oct 2022	Sell	6.16 Cr	₹900.35	68.37 K	Block	0.026949	BSE
25 Oct 2022	Purchase	6.16 Cr	₹900.35	68.37 K	Block	0.026949	BSE
25 Oct 2022	Purchase	13.33 Cr	₹900.35	1.48 L	Block	0.058377	BSE
25 Oct 2022	Sell	13.33 Cr	₹900.35	1.48 L	Block	0.058377	BSE
17 Oct 2022	Purchase	20.70 Cr	₹889.45	2.33 L	Block	0.091731	BSE

Insider trading & SAST

Client name

Manish Kumar Jain

Kaygee Investments Pvt Ltd & Pacs

Pawan Kothari

Mexin Medicaments Pvt. Ltd.

Kaygee Investments Pvt. Ltd.

Paschim Chemicals Pvt. Ltd.

Usha M Chandurkar

Nirmal Jain

Mr. Premchand Godha

Premchand Godha

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
18 Feb 2026	Designated Person	Disposal	0.001182	0.01	44.47 L	₹1,482.22	3 K	16 Feb 2026	Market Sale	20,266	Insider Trading	—	Equity Shares
18 Sep 2025	Promoter	Acquisition	4.02	25.49	0	—	1.02 Cr	20 Aug 2025	Merger	6,46,65,448	SAST	29(2)	—
25 Aug 2025	Designated Person	Disposal	0.000875	0	31.37 L	₹1,413.02	2.22 K	22 Aug 2025	Market Sale	0	Insider Trading	—	Equity Shares
21 Aug 2025	Promoter Group	Disposal	0.005541	0	0	—	14.06 K	20 Aug 2025	Others	0	Insider Trading	—	Equity Shares
21 Aug 2025	Promoter Group	Acquisition	4.015329	25.49	0	—	1.02 Cr	20 Aug 2025	Others	6,46,65,448	Insider Trading	—	Equity Shares
21 Aug 2025	Promoter Group	Disposal	4.009788	0	0	—	1.02 Cr	20 Aug 2025	Others	0	Insider Trading	—	Equity Shares
06 Jan 2025	Promoter	Disposal	1.58	44.72	0	—	40 L	18 Dec 2024	Market	11,34,67,472	SAST	29(2)	—
24 Dec 2024	Promoter	Pledge	0	—	0	—	9.15 K	13 Sep 2017	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	6 L	06 Aug 2015 - 07 Aug 2015	Release	0	SAST	Reg31	—
24 Dec 2024	Promoter	Pledge	—	—	0	—	6 L	31 Mar 2015	Release	6,00,000	SAST	Reg31	—

Ipca Laboratories Share Price

1950.10+0.00 (+0.01%)

+48.90% past 1 Year

IPCA Laboratories Limited incorporated in the year 1949, is integrated pharmaceutical company manufacturing and marketing various formulations and many API’s covering various therapeutic segments. The products of the company are

Corporate Actions

Date

Type

Details

2026-08-07

Dividend

6.0

2025-08-05

Dividend

2.0

2024-11-27

Dividend

2.0

2024-08-06

Dividend

2.0

2023-11-22

Dividend

2.0

2022-11-22

Dividend

4.0

2021-11-22

Dividend

8.0

2020-11-13

Dividend

8.0

2020-02-18

Dividend

5.0

2019-08-06

Dividend

3.0

2018-08-02

Dividend

1.0

2017-07-27

Dividend

1.0

2015-07-22

Dividend

1.0

2014-07-18

Dividend

2.5

2013-10-31

Dividend

2.5

2013-07-19

Dividend

2.0

2012-11-01

Dividend

0

2012-07-20

Dividend

1.2

2012-02-07

Dividend

1.0

2011-11-03

Dividend

1.0

2011-07-18

Dividend

1.2

2011-02-01

Dividend

1.0

2010-10-28

Dividend

1.0

2010-07-16

Dividend

1.0

Company details

Registered office

48 , Kandivli Industrial Estate Kandivli (West) Mumbai Maharashtra PIN: 400067 Tel No: 022- 66474444 / 62106050 Fax No: 022- 62105005 Email: [email protected] Internet: www.ipca.com

Registrars

C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/

Management

Harish P Kamath, Corporate Counsel & Company Secretary, Compliance Officer

Premchand Godha, Chairman

Ajit Kumar Jain, Managing Director & CFO

Pranay Godha, Managing Director & CEO

Prashant Godha, Executive Director

Kamal Kishore Seth, Non Executive Independent Director

Narendra Mairpady, Non Executive Independent Director

Swati Patankar, Non Executive Independent Director

Vivek Shiralkar, Non Executive Independent Director

Details

BSE 524494